23/11/2022
When you think of mistletoe, images of festive cheer and stolen kisses often spring to mind. Yet, this remarkable plant, particularly European Mistletoe (Viscum album), holds a far deeper and more complex history, particularly within the realm of traditional and complementary medicine. Far from being just a Yuletide decoration, mistletoe has been revered for centuries, its unique parasitic nature and purported health benefits making it a subject of enduring fascination and scientific inquiry. But what exactly is mistletoe, how does it grow, and what are the 'types' that influence its medicinal properties?
This article delves into the intriguing world of mistletoe, exploring its botanical identity, the nuances of its various forms, and its documented uses, particularly in European healthcare. We'll examine its traditional applications, its role in modern complementary cancer therapies, and the essential precautions one must consider before contemplating its use. Prepare to look beyond the festive facade and discover the profound complexities of this ancient, and still somewhat mysterious, botanical.

- Understanding Mistletoe: A Botanical Enigma
- The Nuance of 'Types': Mistletoe and Its Host Trees
- Therapeutic Indications of Mistletoe
- Dosage and Administration Guidelines
- Precautions and Contraindications
- Interactions with Medications
- Availability of Mistletoe Products
- Scientific Research and Efficacy
- The Rich History of Mistletoe
- A Pharmacist's Perspective: Tradition, Science, and Mysticism
Understanding Mistletoe: A Botanical Enigma
Mistletoe, scientifically known as Viscum album, is a truly unique plant, setting itself apart from most flora by its very nature of existence. Unlike typical plants that root themselves in soil, mistletoe is an obligate hemiparasite. This means it doesn't grow in the earth; instead, it attaches itself to the bark of host trees, from which it draws water and nutrients (sap). It does, however, produce its own chlorophyll, allowing it to perform photosynthesis, hence the term 'hemiparasite' – it's not entirely dependent on its host for all its nutritional needs. Native to Europe, Asia, and North Africa, its distinctive clusters of evergreen leaves and white, translucent berries are most noticeable during the winter months when deciduous host trees have shed their foliage.
This fascinating growth habit has long contributed to its mystical appeal and its perceived potency in traditional medicine. Without roots in the ground, it seemed to defy conventional botanical rules, leading many ancient cultures to attribute special, even divine, powers to it. Its ability to thrive high in trees, often remaining green when other plants withered, further cemented its status as a plant of life and vitality.
The Nuance of 'Types': Mistletoe and Its Host Trees
While the primary medicinal species is European Mistletoe (Viscum album), the concept of 'types' largely refers to the specific host tree from which the mistletoe is harvested. This distinction is crucial in the preparation of certain therapeutic extracts, particularly those used in complementary cancer treatments. The chemical composition of mistletoe, specifically its lectin content and other active compounds, can vary significantly depending on the tree it parasitises. This variation is believed to influence the specific therapeutic effects of the resulting preparations.
In Europe, particularly in Germany and Switzerland, where mistletoe extracts are widely used as prescription-only adjuvant therapies for cancer, different commercial preparations are often named to indicate their host tree origin. For example:
- IscadorM: Derived from mistletoe grown on apple trees (Malus).
- IscadorP: Derived from mistletoe grown on pine trees (Pinus).
- IscadorQ: Derived from mistletoe grown on oak trees (Quercus).
- IscadorU: Derived from mistletoe grown on elm trees (Ulmus).
These extracts can also differ in other ways, such as whether they are fermented with lactic acid bacteria, contain specific minerals, or are prepared according to homeopathic principles. The idea is that the unique interaction between the mistletoe and its specific host tree imparts subtle yet important differences in its medicinal properties, making certain preparations more suitable for particular conditions or patient profiles. This level of specificity underscores the complex understanding and application of mistletoe in European anthroposophic medicine.
Comparative Overview of Mistletoe Extracts (Host-Dependent)
| Extract Name (Example) | Host Tree | Potential Distinguishing Features | Common Association |
|---|---|---|---|
| IscadorM | Apple (Malus) | Often considered for epithelial tumours. | General support, quality of life. |
| IscadorP | Pine (Pinus) | Sometimes preferred for lung or bone tumours. | Immune modulation. |
| IscadorQ | Oak (Quercus) | Historically associated with glandular tumours. | Stimulation of vitality. |
| IscadorU | Elm (Ulmus) | Less common, specific indications may vary. | Individualised therapy. |
| Eurixor | Various hosts | Standardised lectin content. | Immune system stimulation. |
| Helixor | Various hosts | Different fermentation processes. | Quality of life, tumour regression. |
It is important to note that while these distinctions are central to anthroposophic medical practice, the scientific community continues to research the precise impact of host tree on efficacy. The underlying principle is that the unique 'signature' of the host tree influences the bioactive compounds within the mistletoe, leading to a tailored therapeutic approach.
Therapeutic Indications of Mistletoe
Mistletoe has a long and varied history of medicinal use, evolving from ancient panacea to a subject of modern scientific scrutiny. Its applications today generally fall into two main categories: its well-researched role as an adjuvant cancer treatment and its traditional use for cardiovascular conditions.
Adjuvant Cancer Treatment
Perhaps the most prominent and extensively studied application of mistletoe in contemporary medicine is its use as an adjuvant therapy for cancer. In several European countries, particularly Germany and Switzerland, injectable mistletoe extracts are widely prescribed to patients undergoing conventional cancer treatments like chemotherapy, radiotherapy, and surgery. These preparations are typically administered via subcutaneous injections.
The primary goals of mistletoe therapy in oncology are:
- Slowing Cancer Progression: While not a standalone cure, some studies suggest it can help to slow the growth or spread of certain tumours.
- Improving Quality of Life: This is a key benefit, with patients often reporting reduced side effects from conventional treatments (e.g., fatigue, nausea), improved sleep, appetite, and overall well-being.
- Boosting Immune Function: Mistletoe extracts are believed to modulate the immune system, potentially enhancing the body's natural defences against cancer cells.
- Increasing Survival Time: While some research indicates a potential increase in survival, particularly in certain cancer types, this remains a more debated and less consistently proven benefit, with some studies showing conflicting results.
Specific injectable preparations available in Europe include Iscador, Eurixor, Helixor, Isorel, Iscucin, Plenosol, ABNOBAviscum, Iscar, Vysorel, and Lektinol. These differ in their manufacturing processes, host tree origin, and standardised active components, such as lectins.
It is crucial to highlight that the sale of these injectable mistletoe products is restricted or prohibited in countries like the United States and Canada, primarily due to a lack of regulatory approval for cancer treatment, often citing insufficient rigorous clinical trial data by their standards.
Hypertension and Atherosclerosis
Beyond its oncological applications, mistletoe has a long-standing traditional use for cardiovascular health, specifically in managing mild hypertension (high blood pressure) and preventing atherosclerosis (hardening of the arteries). For these conditions, the leaves and stems of the plant are typically used orally.
Mistletoe is believed to exert a vasodilatory effect, meaning it helps to widen blood vessels, which can contribute to lowering blood pressure and improving blood circulation. While in vitro and animal studies have shown a hypotensive effect, and herbal medicine traditions attest to its long-term utility, there is a notable lack of robust human clinical trials specifically evaluating the oral efficacy of mistletoe for hypertension and atherosclerosis.
Other Historical Uses
Historically, mistletoe was considered a panacea (a universal remedy) by ancient civilisations, particularly the Greeks and Celts. Its traditional applications were incredibly diverse, including treatments for:
- Epilepsy
- Symptoms of menopause
- Infertility
- Nervous states
- Asthma
- Headaches
- Dermatitis
While many of these historical uses are no longer supported by modern scientific evidence, its application for hypertension and atherosclerosis has persisted in traditional herbal medicine, especially in Western Europe, Bulgaria, Turkey, and Mexico. Traditional Chinese Medicine (TCM) also employs mistletoe for alleviating arthritic pain.
Dosage and Administration Guidelines
It is paramount to understand that the therapeutic use of mistletoe, especially for serious conditions like cancer, must always be under the direct supervision of a qualified and trained healthcare professional. The dosages provided below are for informational purposes only and should not be interpreted as medical advice or a recommendation for self-treatment.
Important Note: The internal use of mistletoe is strictly limited to the leaves and stems. The berries of mistletoe are toxic and should never be ingested.
For Mild Hypertension and Atherosclerosis Prevention (Oral Use)
- Maceration: Steep 2 teaspoons of dried, finely chopped leaves in 500 ml of cold water for 10-12 hours. Strain and consume two cups per day.
- Infusion: Infuse 1 to 2 teaspoons of dried, finely chopped leaves in 250 ml of boiling water for 10 minutes. Strain and consume two cups per day.
- Tincture (1:4 – 40-50% alcohol): Take 10 to 60 drops, three times per day.
- Fluid Extract (1:1 – 25-50% alcohol): Take 25 to 60 drops, three times per day.
Always adhere strictly to the recommended dosages and consult with a herbalist or healthcare practitioner knowledgeable in botanical medicine.
Precautions and Contraindications
While European Mistletoe has therapeutic applications, it is not without risks. Careful consideration of precautions and contraindications is essential to ensure patient safety.
Distinguishing Mistletoe Species
Do not confuse European Mistletoe (Viscum album) with American Mistletoe (Phoradendron spp.). American Mistletoe is toxic and does not possess the same documented therapeutic uses as its European counterpart. Always ensure you are using the correct species if considering any form of mistletoe therapy.
General Precautions
- Professional Supervision: Any therapeutic use of mistletoe, particularly injectable forms for cancer, must be supervised by a properly trained and qualified therapist or medical doctor.
- Toxicity of Berries: Mistletoe berries are toxic. Ingestion of even small quantities can cause gastrointestinal upset. Larger quantities can lead to more severe cardiac and neurological issues, including coma and death.
Contraindications
Mistletoe should not be used in the following circumstances:
- Pregnancy or Breastfeeding: Due to insufficient safety data and potential risks, mistletoe is contraindicated during pregnancy and lactation.
- Allergy to Mistletoe: Individuals with known allergies to mistletoe or its components should avoid its use.
Adverse Effects
- Subcutaneous Injections: Common side effects reported with subcutaneous injections include chills, fever, headaches, and pain at the injection site. Serious adverse effects are rare, even with long-term treatment.
- Oral Use: When taken orally at doses exceeding those recommended, mistletoe can be toxic. Accidental ingestion of up to three whole berries or two whole leaves generally appears to be safe, but larger quantities can cause gastrointestinal and cardiac disturbances. Severe overdose can lead to coma or death.
Interactions with Medications
Mistletoe may interact with certain medications, potentially altering their effects. It is vital to discuss all medications and supplements with your healthcare provider before starting mistletoe therapy.
- Antihypertensive Medications: Theoretically, the blood pressure-lowering effects of mistletoe could be additive to those of antihypertensive drugs, potentially leading to excessively low blood pressure (hypotension).
- Immunosuppressant Medications: Given mistletoe's purported immune-modulating properties, it could theoretically counteract the effects of immunosuppressant drugs.
Availability of Mistletoe Products
The availability of mistletoe products varies significantly by region, largely due to differing regulatory frameworks and medical philosophies.
- Injectable Preparations: As mentioned, injectable mistletoe extracts for cancer treatment (e.g., Iscador, Helixor) are prescription-only and widely available in European countries like Germany and Switzerland. However, their distribution is prohibited in Canada and the United States for this indication.
- Oral Preparations: For traditional indications such as hypertension and atherosclerosis, dried mistletoe stems or leaves, as well as fluid extracts, can be found in specialised herbal shops and health food stores in many regions. Solid extracts may also be included in herbal blends designed to support cardiovascular health.
Scientific Research and Efficacy
Extensive research has been conducted on mistletoe, particularly concerning its potential in cancer treatment. While promising, the findings often come with caveats.
Cancer Research
Numerous clinical trials in Europe have investigated the efficacy of subcutaneous mistletoe injections in reducing tumour size or slowing cancer progression. These studies often administer mistletoe alongside conventional treatments (chemotherapy, radiotherapy, surgery) and compare its effects to conventional treatment alone. While the majority of these studies report positive outcomes, particularly regarding patients' quality of life, researchers have often criticised them for methodological weaknesses, such as a lack of placebo controls, blinding, or robust statistical analysis. This has led to some contradictory or inconclusive results regarding direct anti-tumour effects or prolonged survival.
A 2003 meta-analysis of 23 trials (involving 3,500 subjects) presented a more optimistic view, but some critics argue it included studies with significant methodological flaws. The variability in treatment duration, preparation types, dosages, and cancer types (breast, lung, melanoma, bladder, etc.) also makes drawing definitive conclusions challenging.
More recent trials have indicated that subcutaneous mistletoe extracts can indeed improve patients' quality of life and immune performance. While some studies suggest an increase in survival time, this data is less robust and has been contradicted by research, including a study by the German Cancer Society.
Currently, a study funded by the National Center for Complementary and Alternative Medicine (NCCAM) and the National Cancer Institute (NCI) is underway in the United States. It aims to compare chemotherapy alone versus chemotherapy combined with subcutaneous mistletoe extract in patients with advanced tumours, which may provide more definitive answers.
Atherosclerosis and Hypertension Research
Experts generally attribute mistletoe's action on blood vessels and circulation to its vasodilatory properties. In vitro studies and animal models have demonstrated a hypotensive effect. Its long-standing use in herbal medicine also supports its utility in long-term treatment. Many herbal preparations for hypertension in Europe do include mistletoe. However, despite this traditional use, there is a lack of conclusive human clinical trial results specifically demonstrating its efficacy for hypertension and atherosclerosis when administered orally.
The Rich History of Mistletoe
Mistletoe's historical significance is as rich and complex as its botanical nature. In antiquity, it was already highly regarded as a panacea by the ancient Greeks and Celts, who believed it possessed universal healing powers.
- The Celts, particularly the Druids, held mistletoe in sacred esteem, especially when found growing on oak trees. They performed elaborate rituals to harvest it, believing it to be a divine plant with protective and healing properties.
- During the Middle Ages, it was used to treat various ailments, including epilepsy, nervous conditions, and even infertility.
The modern era saw a significant development in mistletoe's therapeutic application. In 1921, the Austrian philosopher and scientist Rudolf Steiner, founder of the anthroposophical movement, hypothesised that mistletoe could be beneficial in cancer treatment. This led to the establishment of medical clinics in Switzerland and Germany dedicated to applying this therapy. Since then, mistletoe therapy has become integrated into the official medical systems of several European countries, primarily focusing on subcutaneous or intramuscular injections of various mistletoe preparations.
It is worth reiterating that medical authorities in Canada and the United States have not authorised this type of injection and do not recognise mistletoe as a cancer medication, highlighting the divergence in medical approaches globally.
A Pharmacist's Perspective: Tradition, Science, and Mysticism
From a pharmaceutical viewpoint, mistletoe remains a fascinating yet challenging plant due to its complex mechanism of action, which is not yet fully elucidated. Its usage is also intertwined with a significant degree of mysticism and philosophical concepts, particularly those stemming from anthroposophy. The primary active compounds are believed to be lectins, proteins capable of binding specifically to cell membranes, which might explain their ability to inhibit the activity of certain cells, including potentially cancer cells.
The complexity is further compounded by the variation in lectin content and composition based on the host tree from which the mistletoe is harvested. As Jean-Yves Dionne, a pharmacist, notes, the understanding of mistletoe's chemistry and mode of action, especially for cancer treatment, is still incomplete. While he acknowledges that recent trials have yielded interesting results, he stresses that mistletoe is not a plant for over-the-counter sale and should only be recommended and supervised by a trained therapist.
The lack of a fully established scientific explanation for all its traditional and observed effects does not necessarily invalidate its potential, but it does underscore the need for caution and continued rigorous research. The journey of mistletoe from ancient reverence to modern medical inquiry is a testament to the enduring human quest for healing, bridging the gap between historical wisdom and contemporary science.
Frequently Asked Questions About Mistletoe
- Is mistletoe poisonous?
- Yes, particularly the berries. Ingesting mistletoe berries can cause gastrointestinal upset, and in larger quantities, it can lead to more serious cardiac and neurological issues. The leaves and stems, when prepared correctly and in appropriate dosages, are used therapeutically, but caution is always advised.
- Can I use mistletoe found in my garden for medicinal purposes?
- No, it is strongly advised against. Firstly, you must correctly identify the species (European Mistletoe vs. American Mistletoe). Secondly, the preparation of medicinal extracts requires specific knowledge, sterile conditions, and precise dosing. Self-medicating with wild-harvested mistletoe is dangerous due to the risk of incorrect identification, improper dosage, and potential toxicity.
- What is the main difference between European and American Mistletoe?
- European Mistletoe (Viscum album) is the species predominantly used for therapeutic purposes, particularly for its immune-modulating properties and its role in complementary cancer therapies in Europe. American Mistletoe (Phoradendron spp.) is considered toxic and has no established therapeutic uses.
- Why is injectable mistletoe used for cancer in Europe but not in the UK or North America?
- The primary reason is regulatory approval. European countries like Germany and Switzerland have integrated mistletoe therapy into their conventional medical systems, based on their interpretation of clinical data and a longer history of its use. In the UK, USA, and Canada, regulatory bodies like the MHRA, FDA, and Health Canada have not approved injectable mistletoe for cancer treatment, citing a lack of sufficient, high-quality clinical trial data that meets their specific standards for efficacy and safety.
- Are there different types of mistletoe in terms of appearance?
- While Viscum album is the main species of medicinal interest, mistletoe plants can vary slightly in appearance based on their host tree and geographical location. However, the most significant 'types' from a therapeutic perspective refer to the extracts derived from mistletoe grown on different host trees, as these variations are believed to influence the chemical composition and therapeutic properties of the preparations.
If you want to read more articles similar to Mistletoe: Unveiling Its Types & Therapeutic Uses, you can visit the Automotive category.
